Quang H. Trinh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Quang H. Trinh has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Binh P. Nguyen
Victoria University of Wellington
5 shared publications - Thanh-Hoang Nguyen-Vo
School of Innovation, Design and Technology, Wellington Institute of Technology, 21 Kensington Avenue, Lower Hutt 5012, New Zealand
4 shared publications - Loc Nguyen
Computational Biology Center, International University−VNU HCMC, Ho Chi Minh City 700000, Vietnam
3 shared publications - Ly Le
School of Biotechnology, International University, Ho Chi Minh City, Vietnam
2 shared publications - Phuong-Uyen Nguyen-Hoang
Computational Biology Center, International University - VNU HCMC, Ho Chi Minh City 700000, Vietnam
2 shared publications Bach Hoai Nguyen
School of Engineering and Computer Science, Victoria University of Wellington, Wellington 6140, New Zealand
1 shared publication
Latest Publications
- 6 December 2024
- Published by American Chemical Society (ACS) in Journal of Chemical Information and Modeling
- Vol. 64 (24) , 9173-9195
From SMILES to Enhanced Molecular Property Prediction: A Unified Multimodal Framework with Predicted 3D Conformers and Contrastive Learning Techniques
We present a novel molecular property prediction framework that requires only the SMILES format as input but is designed to be multimodal by incorporating predicted 3D conformer representations. Our model captures comprehensive molecular features by leveraging both the sequential character structure of SMILES and the three-dimensional spatial structure of conformers. The framework employs contrastive learning techniques, utilizing InfoNCE loss to align SMILES and conformer embeddings, along with task-specific loss functions, such as ConR for regression and SupCon for classification. To address data imbalance, we incorporate feature distribution smoothing (FDS), a common challenge in drug discovery. We evaluated the framework through multiple case studies, including SARS-CoV-2 drug docking score prediction, molecular property prediction using MoleculeNet data sets, and kinase inhibitor prediction for JAK-1, JAK-2, and MAPK-14 using custom data sets curated from PubChem. The results consistently outperformed state-of-the-art methods, with ConR and FDS significantly improving regression tasks and SupCon enhancing classification performance. These findings highlight the flexibility and robustness of our multimodal model, demonstrating its effectiveness across diverse molecular property prediction tasks, with promising applications in drug discovery and molecular analysis.
- 6 December 2024
- Published by American Chemical Society (ACS) in Journal of Chemical Information and Modeling
- Vol. 64 (24) , 9173-9195
From SMILES to Enhanced Molecular Property Prediction: A Unified Multimodal Framework with Predicted 3D Conformers and Contrastive Learning Techniques
We present a novel molecular property prediction framework that requires only the SMILES format as input but is designed to be multimodal by incorporating predicted 3D conformer representations. Our model captures comprehensive molecular features by leveraging both the sequential character structure of SMILES and the three-dimensional spatial structure of conformers. The framework employs contrastive learning techniques, utilizing InfoNCE loss to align SMILES and conformer embeddings, along with task-specific loss functions, such as ConR for regression and SupCon for classification. To address data imbalance, we incorporate feature distribution smoothing (FDS), a common challenge in drug discovery. We evaluated the framework through multiple case studies, including SARS-CoV-2 drug docking score prediction, molecular property prediction using MoleculeNet data sets, and kinase inhibitor prediction for JAK-1, JAK-2, and MAPK-14 using custom data sets curated from PubChem. The results consistently outperformed state-of-the-art methods, with ConR and FDS significantly improving regression tasks and SupCon enhancing classification performance. These findings highlight the flexibility and robustness of our multimodal model, demonstrating its effectiveness across diverse molecular property prediction tasks, with promising applications in drug discovery and molecular analysis.
- 4 March 2024
- Published by American Chemical Society (ACS) in Journal of Chemical Information and Modeling
- Vol. 64 (6) , 1816-1827
Predicting Cardiotoxicity of Molecules Using Attention-Based Graph Neural Networks
In drug discovery, the search for new and effective medications is often hindered by concerns about toxicity. Numerous promising molecules fail to pass the later phases of drug development due to strict toxicity assessments. This challenge significantly increases the cost, time, and human effort needed to discover new therapeutic molecules. Additionally, a considerable number of drugs already on the market have been withdrawn or re-evaluated because of their unwanted side effects. Among the various types of toxicity, drug-induced heart damage is a severe adverse effect commonly associated with several medications, especially those used in cancer treatments. Although a number of computational approaches have been proposed to identify the cardiotoxicity of molecules, the performance and interpretability of the existing approaches are limited. In our study, we proposed a more effective computational framework to predict the cardiotoxicity of molecules using an attention-based graph neural network. Experimental results indicated that the proposed framework outperformed the other methods. The stability of the model was also confirmed by our experiments. To assist researchers in evaluating the cardiotoxicity of molecules, we have developed an easy-to-use online web server that incorporates our model.
- 4 March 2024
- Published by American Chemical Society (ACS) in Journal of Chemical Information and Modeling
- Vol. 64 (6) , 1816-1827
Predicting Cardiotoxicity of Molecules Using Attention-Based Graph Neural Networks
In drug discovery, the search for new and effective medications is often hindered by concerns about toxicity. Numerous promising molecules fail to pass the later phases of drug development due to strict toxicity assessments. This challenge significantly increases the cost, time, and human effort needed to discover new therapeutic molecules. Additionally, a considerable number of drugs already on the market have been withdrawn or re-evaluated because of their unwanted side effects. Among the various types of toxicity, drug-induced heart damage is a severe adverse effect commonly associated with several medications, especially those used in cancer treatments. Although a number of computational approaches have been proposed to identify the cardiotoxicity of molecules, the performance and interpretability of the existing approaches are limited. In our study, we proposed a more effective computational framework to predict the cardiotoxicity of molecules using an attention-based graph neural network. Experimental results indicated that the proposed framework outperformed the other methods. The stability of the model was also confirmed by our experiments. To assist researchers in evaluating the cardiotoxicity of molecules, we have developed an easy-to-use online web server that incorporates our model.
- 14 February 2022
- Published by American Chemical Society (ACS) in Journal of Chemical Information and Modeling
- Vol. 62 (21) , 5080-5089
iANP-EC: Identifying Anticancer Natural Products Using Ensemble Learning Incorporated with Evolutionary Computation
Cancer is one of the most deadly diseases that annually kills millions of people worldwide. The investigation on anticancer medicines has never ceased to seek better and more adaptive agents with fewer side effects. Besides chemically synthetic anticancer compounds, natural products are scientifically proved as a highly potential alternative source for anticancer drug discovery. Along with experimental approaches being used to find anticancer drug candidates, computational approaches have been developed to virtually screen for potential anticancer compounds. In this study, we construct an ensemble computational framework, called iANP-EC, using machine learning approaches incorporated with evolutionary computation. Four learning algorithms (k-NN, SVM, RF, and XGB) and four molecular representation schemes are used to build a set of classifiers, among which the top-four best-performing classifiers are selected to form an ensemble classifier. Particle swarm optimization (PSO) is used to optimise the weights used to combined the four top classifiers. The models are developed by a set of curated 997 compounds which are collected from the NPACT and CancerHSP databases. The results show that iANP-EC is a stable, robust, and effective framework that achieves an AUC-ROC value of 0.9193 and an AUC-PR value of 0.8366. The comparative analysis of molecular substructures between natural anticarcinogens and nonanticarcinogens partially unveils several key substructures that drive anticancerous activities. We also deploy the proposed ensemble model as an online web server with a user-friendly interface to support the research community in identifying natural products with anticancer activities.
- 14 February 2022
- Published by American Chemical Society (ACS) in Journal of Chemical Information and Modeling
- Vol. 62 (21) , 5080-5089
iANP-EC: Identifying Anticancer Natural Products Using Ensemble Learning Incorporated with Evolutionary Computation
Cancer is one of the most deadly diseases that annually kills millions of people worldwide. The investigation on anticancer medicines has never ceased to seek better and more adaptive agents with fewer side effects. Besides chemically synthetic anticancer compounds, natural products are scientifically proved as a highly potential alternative source for anticancer drug discovery. Along with experimental approaches being used to find anticancer drug candidates, computational approaches have been developed to virtually screen for potential anticancer compounds. In this study, we construct an ensemble computational framework, called iANP-EC, using machine learning approaches incorporated with evolutionary computation. Four learning algorithms (k-NN, SVM, RF, and XGB) and four molecular representation schemes are used to build a set of classifiers, among which the top-four best-performing classifiers are selected to form an ensemble classifier. Particle swarm optimization (PSO) is used to optimise the weights used to combined the four top classifiers. The models are developed by a set of curated 997 compounds which are collected from the NPACT and CancerHSP databases. The results show that iANP-EC is a stable, robust, and effective framework that achieves an AUC-ROC value of 0.9193 and an AUC-PR value of 0.8366. The comparative analysis of molecular substructures between natural anticarcinogens and nonanticarcinogens partially unveils several key substructures that drive anticancerous activities. We also deploy the proposed ensemble model as an online web server with a user-friendly interface to support the research community in identifying natural products with anticancer activities.
- 21 October 2021
- Published by American Chemical Society (ACS) in Journal of Chemical Information and Modeling
- Vol. 62 (21) , 5059-5068
iCYP-MFE: Identifying Human Cytochrome P450 Inhibitors Using Multitask Learning and Molecular Fingerprint-Embedded Encoding
The human cytochrome P450 (CYP) superfamily holds responsibilities for the metabolism of both endogenous and exogenous compounds such as drugs, cellular metabolites, and toxins. The inhibition exerted on the CYP enzymes is closely associated with adverse drug reactions encompassing metabolic failures and induced side effects. In modern drug discovery, identification of potential CYP inhibitors is, therefore, highly essential. Alongside experimental approaches, numerous computational models have been proposed to address this biochemical issue. In this study, we introduce iCYP-MFE, a computational framework for virtual screening on CYP inhibitors toward 1A2, 2C9, 2C19, 2D6, and 3A4 isoforms. iCYP-MFE contains a set of five robust, stable, and effective prediction models developed using multitask learning incorporated with molecular fingerprint-embedded features. The results show that multitask learning can remarkably leverage useful information from related tasks to promote global performance. Comparative analysis indicates that iCYP-MFE achieves three predominant tasks, one equivalent task, and one less effective task compared to state-of-the-art methods. The area under the receiver operating characteristic curve (AUC-ROC) and the area under the precision-recall curve (AUC-PR) were two decisive metrics used for model evaluation. The prediction task for CYP2D6-inhibition achieves the highest AUC-ROC value of 0.93 while the prediction task for CYP1A2-inhibition obtains the highest AUC-PR value of 0.92. The substructural analysis preliminarily explains the nature of the CYP-inhibitory activity of compounds. An online web server for iCYP-MFE with a user-friendly interface was also deployed to support scientific communities in identifying CYP inhibitors.
- 21 October 2021
- Published by American Chemical Society (ACS) in Journal of Chemical Information and Modeling
- Vol. 62 (21) , 5059-5068
iCYP-MFE: Identifying Human Cytochrome P450 Inhibitors Using Multitask Learning and Molecular Fingerprint-Embedded Encoding
The human cytochrome P450 (CYP) superfamily holds responsibilities for the metabolism of both endogenous and exogenous compounds such as drugs, cellular metabolites, and toxins. The inhibition exerted on the CYP enzymes is closely associated with adverse drug reactions encompassing metabolic failures and induced side effects. In modern drug discovery, identification of potential CYP inhibitors is, therefore, highly essential. Alongside experimental approaches, numerous computational models have been proposed to address this biochemical issue. In this study, we introduce iCYP-MFE, a computational framework for virtual screening on CYP inhibitors toward 1A2, 2C9, 2C19, 2D6, and 3A4 isoforms. iCYP-MFE contains a set of five robust, stable, and effective prediction models developed using multitask learning incorporated with molecular fingerprint-embedded features. The results show that multitask learning can remarkably leverage useful information from related tasks to promote global performance. Comparative analysis indicates that iCYP-MFE achieves three predominant tasks, one equivalent task, and one less effective task compared to state-of-the-art methods. The area under the receiver operating characteristic curve (AUC-ROC) and the area under the precision-recall curve (AUC-PR) were two decisive metrics used for model evaluation. The prediction task for CYP2D6-inhibition achieves the highest AUC-ROC value of 0.93 while the prediction task for CYP1A2-inhibition obtains the highest AUC-PR value of 0.92. The substructural analysis preliminarily explains the nature of the CYP-inhibitory activity of compounds. An online web server for iCYP-MFE with a user-friendly interface was also deployed to support scientific communities in identifying CYP inhibitors.
- 16 August 2021
- Published by American Chemical Society (ACS) in Journal of Chemical Information and Modeling
- Vol. 62 (21) , 5050-5058
Predicting Antimalarial Activity in Natural Products Using Pretrained Bidirectional Encoder Representations from Transformers
Malaria is a threatening disease that has claimed many lives and has a high prevalence rate annually. Through the past decade, there have been many studies to uncover effective antimalarial compounds to combat this disease. Alongside chemically synthesized chemicals, a number of natural compounds have also been proven to be as effective in their antimalarial properties. Besides experimental approaches to investigate antimalarial activities in natural products, computational methods have been developed with satisfactory outcomes obtained. In this study, we propose a novel molecular encoding scheme based on Bidirectional Encoder Representations from Transformers and used our pretrained encoding model called NPBERT with four machine learning algorithms, including k-Nearest Neighbors (k-NN), Support Vector Machines (SVM), eXtreme Gradient Boosting (XGB), and Random Forest (RF), to develop various prediction models to identify antimalarial natural products. The results show that SVM models are the best-performing classifiers, followed by the XGB, k-NN, and RF models. Additionally, comparative analysis between our proposed molecular encoding scheme and existing state-of-the-art methods indicates that NPBERT is more effective compared to the others. Moreover, the deployment of transformers in constructing molecular encoders is not limited to this study but can be utilized for other biomedical applications.
- 16 August 2021
- Published by American Chemical Society (ACS) in Journal of Chemical Information and Modeling
- Vol. 62 (21) , 5050-5058
Predicting Antimalarial Activity in Natural Products Using Pretrained Bidirectional Encoder Representations from Transformers
Malaria is a threatening disease that has claimed many lives and has a high prevalence rate annually. Through the past decade, there have been many studies to uncover effective antimalarial compounds to combat this disease. Alongside chemically synthesized chemicals, a number of natural compounds have also been proven to be as effective in their antimalarial properties. Besides experimental approaches to investigate antimalarial activities in natural products, computational methods have been developed with satisfactory outcomes obtained. In this study, we propose a novel molecular encoding scheme based on Bidirectional Encoder Representations from Transformers and used our pretrained encoding model called NPBERT with four machine learning algorithms, including k-Nearest Neighbors (k-NN), Support Vector Machines (SVM), eXtreme Gradient Boosting (XGB), and Random Forest (RF), to develop various prediction models to identify antimalarial natural products. The results show that SVM models are the best-performing classifiers, followed by the XGB, k-NN, and RF models. Additionally, comparative analysis between our proposed molecular encoding scheme and existing state-of-the-art methods indicates that NPBERT is more effective compared to the others. Moreover, the deployment of transformers in constructing molecular encoders is not limited to this study but can be utilized for other biomedical applications.